Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption.
Dasatinib protects humanized mice from acute HIV-1 infection.
Tuberculosis-associated IFN-I induces Siglec-1 on tunneling nanotubes and favors HIV-1 spread in macrophages.
Methylation regulation of Antiviral host factors, Interferon Stimulated Genes (ISGs) and T-cell responses associated with natural HIV control.
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.
Anti-Siglec-1 antibodies block Ebola viral uptake and decrease cytoplasmic viral entry.
Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study).
Cancer immunotherapy of patients with HIV infection.
Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix.
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting.